IL-17与干扰素-γ协同激活血管基质细胞促进巨细胞动脉炎炎症
该研究探讨IL-17在巨细胞动脉炎(GCA)中的作用。方法为对颞动脉活检组织体外培养后行RNA测序和qPCR,并分析肌纤维母细胞。结果显示IL-17通过上调IL-6、GM-CSF等促炎因子加剧血管炎症,且与IFN-γ协同增强此效应,提示IL-17是GCA发病的关键 contributor。
要点
- IL-17上调GCA血管基质细胞中IL-6、CCL20、GM-CSF等促炎因子。
- IFN-γ增强IL-17受体表达,与IL-17协同放大炎症反应。
- 司库奇尤单抗可逆转IL-17驱动的促炎表型。
核心结论
- IL-17通过激活肌纤维母细胞并与IFN-γ协同,加剧GCA血管炎症。
研究设计与样本
- 对颞动脉活检组织在MATRIGEL中体外培养,分别加入IL-17、司库奇尤单抗或对照IgG,行bulk RNA测序和实时定量PCR。
- 比较阳性与阴性颞动脉活检,并利用肌纤维母细胞体外培养、共聚焦显微镜及外周血单核细胞共培养研究T细胞极化。
主要发现
- 司库奇尤单抗处理阳性颞动脉活检降低血管炎症相关基因表达,尤其IL6。
- qPCR证实司库奇尤单抗降低阳性活检中IL-6、CCL20和GM-CSF mRNA,而IL-17在阴性活检中上调这些基因。
- 血管重塑相关基因表达无变化。
- IL-17受体链表达于肌纤维母细胞,且IFN-γ增强其表达。
- IL-17上调肌纤维母细胞中IL-6、CCL20、CCL2、GM-CSF和VEGF,司库奇尤单抗可逆转;加入IFN-γ产生协同效应。
临床怎么用
- 提示IL-17轴是GCA血管炎症的潜在治疗靶点,司库奇尤单抗可能减轻血管炎症。
- IFN-γ增强IL-17受体表达,提示联合阻断IL-17与IFN-γ通路可能更有效。
局限性
- 研究为体外实验,样本量未报告,临床相关性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study investigated the role of interleukin-17 (IL-17) in giant cell arteritis (GCA), which has remained uncertain despite previous research suggesting a contribution of Th17 cells to the disease. METHODS: Temporal artery biopsies (TABs) were cultured ex vivo in MATRIGEL with IL-17, secukinumab, or control IgG and subsequently analyzed using bulk RNA-sequencing and real-time quantitative polymerase chain reaction. Positive TABs with GCA features were compared to negative TABs or used to obtain in vitro cultures of myofibroblasts (MFs). Confocal microscopy analyzed IL-17 receptor expression. MFs and peripheral blood mononuclear cells cocultures were used to study T cell polarization. RESULTS: Transcriptomic analysis showed that secukinumab treatment of positive TABs reduced expression of genes linked to vascular inflammation, notably IL6. Real-time quantitative polymerase chain reaction analysis confirmed that secukinumab decreased messenger RNA encoding IL-6, CCL20, and granulocyte macrophage colony-stimulating factor (GM-CSF) in positive TABs, whereas IL-17 up-regulated them in negative TABs. No changes were observed regarding the expression of genes related to vascular remodeling. IL-17 receptor chains were expressed on MFs, and their expression was enhanced by interferon-γ (IFN-γ). Real-time quantitative polymerase chain reaction and Luminex analyses confirmed IL-17-driven upregulation of IL-6, CCL20, CCL2, GM-CSF, and vascular endothelial growth factor (VEGF) in MFs, which was reversed by secukinumab. Addition of IFN-γ to the culture increased the expression level of IL-17 receptor chains, resulting in a synergistic effect. Additionally, IL-17-pretreated MFs promoted Th17 polarization. CONCLUSION: IL-17 exacerbates vascular inflammation in GCA by activating MFs and synergizing with IFN-γ to increase production of proinflammatory cytokines (IL-6, GM-CSF), chemokines (CCL20, CCL2), and angiogenic factors (VEGF), indicating that IL-17 is a key contributor to disease pathogenesis.
引用
- Greigert H, Ramon A, Cladiere C, et al. In Synergy With Interferon-γ, Interleukin-17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis. Arthritis Rheumatol. 2026. PMID: 41524618. doi:10.1002/art.70051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。